Ray Dalio’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.1M Buy
195,118
+1,334
+0.7% +$383K 0.23% 82
2025
Q1
$59.7M Buy
193,784
+86,054
+80% +$26.5M 0.28% 79
2024
Q4
$38M Buy
107,730
+45,975
+74% +$16.2M 0.17% 105
2024
Q3
$22.1M Buy
61,755
+49,003
+384% +$17.6M 0.13% 145
2024
Q2
$4.06M Buy
12,752
+4,802
+60% +$1.53M 0.02% 395
2024
Q1
$1.83M Sell
7,950
-1,069
-12% -$246K 0.01% 509
2023
Q4
$1.98M Sell
9,019
-9,128
-50% -$2.01M 0.01% 518
2023
Q3
$4.1M Sell
18,147
-22,658
-56% -$5.12M 0.02% 387
2023
Q2
$9.01M Sell
40,805
-460
-1% -$102K 0.06% 215
2023
Q1
$9.24M Buy
41,265
+16,161
+64% +$3.62M 0.06% 214
2022
Q4
$6.98M Sell
25,104
-19,113
-43% -$5.32M 0.04% 300
2022
Q3
$9.26M Sell
44,217
-10,209
-19% -$2.14M 0.05% 264
2022
Q2
$12.8M Buy
+54,426
New +$12.8M 0.05% 281
2019
Q2
Sell
-9,124
Closed -$1.07M 366
2019
Q1
$1.07M Buy
+9,124
New +$1.07M 0.01% 240
2018
Q4
Sell
-53,726
Closed -$6.87M 517
2018
Q3
$6.87M Buy
53,726
+8,401
+19% +$1.07M 0.07% 101
2018
Q2
$5.13M Sell
45,325
-116,024
-72% -$13.1M 0.05% 134
2018
Q1
$18.1M Buy
161,349
+67,626
+72% +$7.6M 0.17% 39
2017
Q4
$13.9M Buy
93,723
+953
+1% +$141K 0.11% 38
2017
Q3
$10.9M Buy
92,770
+18,802
+25% +$2.2M 0.07% 72
2017
Q2
$9.6M Buy
73,968
+15,876
+27% +$2.06M 0.09% 59
2017
Q1
$7.86M Buy
58,092
+14,187
+32% +$1.92M 0.09% 69
2016
Q4
$6.3M Sell
43,905
-69,900
-61% -$10M 0.06% 116
2016
Q3
$13.4M Buy
113,805
+49,705
+78% +$5.87M 0.13% 47
2016
Q2
$6.79M Sell
64,100
-21,733
-25% -$2.3M 0.09% 92
2016
Q1
$9.56M Buy
85,833
+57,672
+205% +$6.43M 0.12% 53
2015
Q4
$4.41M Buy
+28,161
New +$4.41M 0.06% 129